Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels

Recruiting

Vagus Nerve StimulationEffect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels

Sponsor:

Indiana University

Code:

NCT06597149

Conditions

Healthy

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

Transcutaneous Auricular Vagus Nerve Stimulation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-28. This information was provided to ClinicalTrials.gov by Indiana University on 2025-11-18.